ES2128592T3 - Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios. - Google Patents

Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios.

Info

Publication number
ES2128592T3
ES2128592T3 ES94931136T ES94931136T ES2128592T3 ES 2128592 T3 ES2128592 T3 ES 2128592T3 ES 94931136 T ES94931136 T ES 94931136T ES 94931136 T ES94931136 T ES 94931136T ES 2128592 T3 ES2128592 T3 ES 2128592T3
Authority
ES
Spain
Prior art keywords
enantiomerical
leucine
analogs
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931136T
Other languages
English (en)
Spanish (es)
Inventor
Nicholas Turner
James Winterman
Raymond Mccague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chirotech Technology Ltd
Original Assignee
Chirotech Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chirotech Technology Ltd filed Critical Chirotech Technology Ltd
Application granted granted Critical
Publication of ES2128592T3 publication Critical patent/ES2128592T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES94931136T 1993-11-01 1994-11-01 Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios. Expired - Lifetime ES2128592T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939322472A GB9322472D0 (en) 1993-11-01 1993-11-01 Chiral compounds and their preparation

Publications (1)

Publication Number Publication Date
ES2128592T3 true ES2128592T3 (es) 1999-05-16

Family

ID=10744442

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931136T Expired - Lifetime ES2128592T3 (es) 1993-11-01 1994-11-01 Procedimiento para preparar terc-leucina y analogos de la misma en forma enantiomerica y productos intermedios.

Country Status (10)

Country Link
US (1) US6180374B1 (de)
EP (1) EP0726891B1 (de)
JP (1) JPH09504304A (de)
AT (1) ATE176461T1 (de)
AU (1) AU676786B2 (de)
CA (1) CA2173205A1 (de)
DE (1) DE69416424T2 (de)
ES (1) ES2128592T3 (de)
GB (1) GB9322472D0 (de)
WO (1) WO1995012573A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529211C2 (de) * 1995-08-09 1999-01-14 Degussa Verfahren zur Herstellung von (R)-tertiär-Leucin
CA2250417A1 (en) * 1996-04-02 1997-10-09 Bayer Aktiengesellschaft Substituted phenyl keto enols as pesticides and herbicides
GB9607458D0 (en) * 1996-04-10 1996-06-12 Zeneca Ltd Enzymatic process for stereoselective preparation of therapeutic amides
US6130337A (en) * 1997-04-11 2000-10-10 Board Of Trustees Of Leland Stanford Junior University Enantiomerically enriched α,α-distributed amino acids and method
JP2000319241A (ja) * 1999-04-28 2000-11-21 Ihara Chem Ind Co Ltd フェニルアルカン酸アミド化合物の製造方法
WO2009063804A1 (ja) 2007-11-16 2009-05-22 Kaneka Corporation Ｎ－カルバモイル－ｔｅｒｔ－ロイシンの製造法
EP2238242B9 (de) 2008-01-03 2015-06-10 BASF Enzymes LLC Transferasen und oxidoreduktasen, dafür kodierende nukleinsäuren sowie verfahren zu ihrer herstellung und verwendung
KR20120026024A (ko) 2009-04-24 2012-03-16 가부시키가이샤 가네카 Ｎ-알콕시카르보닐-ｔｅｒｔ-류신의 제조법
US8835676B2 (en) 2011-03-21 2014-09-16 Divi's Laboratories Ltd. Process for the preparation of enantiomerically pure tert-leucine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541080A (en) 1991-11-01 1996-07-30 Wisconsin Alumni Research Fdn. Method for preparing L-alpha-amino acids
US5219731A (en) * 1991-11-01 1993-06-15 Wisconsin Alumni Research Foundation Method for preparing optically-active amino acid derivatives

Also Published As

Publication number Publication date
AU676786B2 (en) 1997-03-20
DE69416424D1 (de) 1999-03-18
ATE176461T1 (de) 1999-02-15
GB9322472D0 (en) 1993-12-22
CA2173205A1 (en) 1995-05-11
EP0726891A1 (de) 1996-08-21
EP0726891B1 (de) 1999-02-03
JPH09504304A (ja) 1997-04-28
DE69416424T2 (de) 1999-06-10
WO1995012573A1 (en) 1995-05-11
US6180374B1 (en) 2001-01-30
AU8001294A (en) 1995-05-23

Similar Documents

Publication Publication Date Title
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
CA2083041A1 (en) Labeled compounds for use in a diagnostic breath test
DK0682561T3 (da) Omdannelse af kulstof eller kulstofholdige forbindelser i et plasma
GB9300763D0 (en) Chemical compound
PH21581A (en) B-lactams and process for preparing the same
GB9322472D0 (en) Chiral compounds and their preparation
CA2080221A1 (en) An improved process for the preparation of substituted indolone derivatives
ES2195312T3 (es) Copolimeros de alfa-olefina-cicloolefina y procedimiento para su preparacion.
DK0383686T3 (da) Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf
EP0220951A3 (de) Mit stabilen Isotopen markierte biochemische Produkte
EP0298336B1 (en) Aromatic polyisocyanates, process for their preparation and their use as components of adhesives
IE890175L (en) Aminoacid glycerides.
IN169689B (de)
ES8500228A1 (es) Procedimiento para desdoblar mezclas racemicas de esteres de acidos imino- -carboxilicos biciclicos
TW333528B (en) Adhesion receptor antagonists
MX9602482A (es) Sujetador de tipo de grapa.
JPS571441A (en) Deodorizing agent
GR3002283T3 (en) Synthesis of peptidamides by the solid phase method using anchor groups unstable as to acids
HUT58766A (en) Process for producing new pentapeptides
HU9403715D0 (en) A process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
MY129238A (en) Anticonvulsant derivatives useful in treating essential tremor
DE3267690D1 (en) Process for the preparation of 3-alkyl-6-methyl-beta-resorcylic-acid esters
DE3855751D1 (en) Hypoglycemische peptide
JPS55114293A (en) Production of l-glutamic acid
ES2007598A6 (es) Composicion a base de derivados de fosfonatos amonicos y procedimientopara regular con ella el crecimiento de las plantas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 726891

Country of ref document: ES